CTI BioPharma Corp. (CTIC) has a market capitalization of $1.2B and trades at $9.10. The 52-week range is 4.01-9.1.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of -11.5, Earnings Per Share (EPS) of $-0.79, annual revenue of $53.95M.
The stock has a beta of 0.83, operates in the Healthcare sector.
